Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Encourages working women to practice self-care
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
There are 38.4 million people with diabetes in the United States
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Subscribe To Our Newsletter & Stay Updated